Publications by authors named "J-B Chevaux"
Article Synopsis
- EUS-guided hepaticojejunostomy (EUS-HJS) is a biliary drainage technique for patients with altered anatomy, particularly those who have had total gastrectomy, but data on its effectiveness were previously lacking.
- A retrospective study involving 21 patients found that EUS-HJS achieved 100% technical success and 80% clinical success, helping to alleviate symptoms like jaundice and cholangitis.
- Although the procedure had a 33% adverse event rate, many patients (39%) could resume cancer treatment, and the median survival time after the procedure was 6 months.
Introduction: The environmental impact of endoscopy, including small-bowel capsule endoscopy (SBCE), is a topic of growing attention and concern. This study aimed to evaluate the greenhouse gas (GHG) emissions (kgCO) generated by an SBCE procedure.
Methods: Life cycle assessment methodology (ISO 14040) was used to evaluate three brands of SBCE device and included emissions generated by patient travel, bowel preparation, capsule examination, and video recording.
Background: Endoscopic resection of adenomas prevents colorectal cancer, but the optimal technique for larger lesions is controversial. Piecemeal endoscopic mucosal resection (EMR) has a low adverse event (AE) rate but a variable recurrence rate necessitating early follow-up. Endoscopic submucosal dissection (ESD) can reduce recurrence but may increase AEs.
View Article and Find Full Text PDFUse of endoscopic submucosal dissection or full-thickness resection device to treat residual colorectal neoplasia after endoscopic resection: a multicenter historical cohort study.
Endoscopy
November 2023
INTRODUCTION : Residual colorectal neoplasia (RCN) after previous endoscopic mucosal resection is a frequent challenge. Different management techniques are feasible including endoscopic full-thickness resection using the full-thickness resection device (FTRD) system and endoscopic submucosal dissection (ESD). We aimed to compare the efficacy and safety of these two techniques for the treatment of such lesions.
View Article and Find Full Text PDFArticle Synopsis
- - The COVID-19 pandemic has significantly changed how patients with inflammatory bowel disease (IBD) are managed during endoscopic procedures due to the risk of SARS-CoV-2 transmission.
- - Key preventive measures include using personal protective equipment (PPE), improving hygiene in endoscopy rooms, and postponing non-urgent procedures to protect patients and healthcare workers.
- - This Perspective draws from experiences in Italy and France to offer guidelines on PPE use, as well as suggestions for when to reschedule endoscopies or use alternative biomarkers in managing IBD.